Type 2 Diabetes Trial, Recruiting NCT07129915 Sponsor: Yunxuan Li Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07129915
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been formally diagnosed with type 2 diabetes
  • People who are 18 years of age or older
  • People whose cognitive (thinking and memory) function has been assessed as normal, based on a short screening test called the Mini-Cog
  • People who are able to independently use WeChat on a smartphone
  • People who are willing to take part and sign a consent form agreeing to participate

Who may not be able to join:

  • People who have serious sudden diabetes-related complications, such as diabetic ketoacidosis or hyperosmolar coma (confirm with trial site)
  • People who have a diagnosed condition affecting memory or thinking, such as dementia or Alzheimer's disease
  • People who are currently taking part in another clinical trial
  • People whose life expectancy is estimated to be less than 6 months
  • People who are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613939809540

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Yunxuan Li
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
31 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Glycated Hemoglobin (HbA1c) Level; Diabetes Self-Management Capacity Scale Score; Shared Decision Making Questionnaire (SDM-Q-9) Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov